Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-03-15
2005-03-15
Acquah, Samuel A. (Department: 1711)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C528S361000, C528S363000, C528S365000, C525S437000, C525S444000, C525S450000, C525S054100, C514S772300, C514S772600, C514S773000, C514S800000, C514S806000, C514S807000, C514S808000, C514S809000, C424S457000, C424S477000
Reexamination Certificate
active
06867181
ABSTRACT:
A method of spherifying a sustained release ionic conjugate which contains a free carboxyl group-containing polymer and a free amino group-containing drug which are ionically bonded to each other.
REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4356166 (1982-10-01), Peterson et al.
patent: 4609707 (1986-09-01), Nowinski et al.
patent: 4767628 (1988-08-01), Hutchinson
patent: 5071909 (1991-12-01), Pappin et al.
patent: 5084553 (1992-01-01), Hess et al.
patent: 5162505 (1992-11-01), Dean et al.
patent: 5476653 (1995-12-01), Pitt et al.
patent: 5569467 (1996-10-01), Ruiz
patent: 5672659 (1997-09-01), Shalaby et al.
patent: 5863985 (1999-01-01), Shalaby et al.
patent: 6221958 (2001-04-01), Shalaby et al.
patent: 1115252 (1996-01-01), None
patent: 44 16812 (1994-11-01), None
patent: 0 107 591 (1984-05-01), None
patent: 0 426 055 (1991-05-01), None
patent: 0 426 055 (1991-05-01), None
patent: 0 467 389 (1992-01-01), None
patent: 0 467 389 (1992-01-01), None
patent: 0 483 429 (1992-05-01), None
patent: WO 9211844 (1992-07-01), None
patent: WO 9317668 (1993-09-01), None
patent: WO 9415587 (1994-07-01), None
patent: WO 9739738 (1997-10-01), None
patent: WO 9740085 (1997-10-01), None
Mehta, Rahul C. et al., “Biodegradable Microspheres as Depot System for Parenteral Delivery of Peptide Drugs”, J of Controlled Release, vol. 29, pp 375-384 (1994).
Shah, S.S. et al., “Poly (glycolic acid-co-DL-lactic acid) : Diffusion or Degradation Controlled Drug Delivery?”, J. of Controlled Release, vol. 18, pp 261-270 (1992).
Srkalovic, G. et al., Abstract “Receptors for Luteinizing Hormone-releasing Hormone (LH-RH) in Dunning R3327 Prostate Cancers and Rat Anterior Pituitaries after Treament with a Sustained Delivery System of LH-RH antagonist SB-75”, Chemical Abstracts, vol. 114, No. 3 (1991) XP-002070850.
Jackson Steven A.
Moreau Jacques-Pierre
Shalaby Shalaby Wahba
Acquah Samuel A.
Feeney Alan F.
Fish & Richardson
Morrill Brian R.
Poly-Med, Incorporated
LandOfFree
Ionic molecular conjugates of biodegradable polyesters and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ionic molecular conjugates of biodegradable polyesters and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ionic molecular conjugates of biodegradable polyesters and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3455668